Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

VOLUME 4 , ISSUE 2 ( April-June, 2010 ) > List of Articles

REVIEW ARTICLE

What is the Role of Three-dimensional Ultrasound in Reproductive Medicine?

Po Mui Lam, Christopher Haines

Keywords : Reproductive medicine,three-dimensional,ultrasound

Citation Information : Lam PM, Haines C. What is the Role of Three-dimensional Ultrasound in Reproductive Medicine?. Donald School J Ultrasound Obstet Gynecol 2010; 4 (2):169-177.

DOI: 10.5005/jp-journals-10009-1140

License: CC BY-NC 4.0

Published Online: 01-06-2010

Copyright Statement:  Copyright © 2010; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

This article reviews the merits of three-dimensional (3D) ultrasound and thereby establishes its clinical and research role in reproductive medicine. Its main clinical applications include the assessment for uterine anomalies and intrauterine pathology, especially, if combined with the procedure of saline infusion into the uterine cavity. Moreover, 3D color Doppler sonography is an exciting research tool for the evaluation of endometrial receptivity, ovarian reserve, and polycystic ovaries.


PDF Share
  1. Measurements of organ volume by ultrasonography. Proc Inst Mech Eng [H] 1999;213(3):247-59.
  2. The interobserver reliability of ovarian volume measurement is improved with three-dimensional ultrasound, but dependent upon technique. Ultrasound Med Biol 2003;29(12):1685-90.
  3. Three-dimensional transvaginal ultrasound in gynecological diagnosis. Ultrasound Obstet Gynecol 1999; 14(2):81-86.
  4. The reproducibility of endometrial volume acquisition and measurement with the VOCAL-imaging program. Ultrasound Obstet Gynecol 2002;19(1):69-75.
  5. The interobserver reliability and validity of volume calculation from three-dimensional ultrasound datasets in the in vitro setting. Ultrasound Obstet Gynecol 2003;21(3):283-91.
  6. Three-dimensional ultrasound: Accuracy of distance and volume measurements. Ultrasound Obstet Gynecol 1996;7(6):429-34.
  7. In vivo three-dimensional sonographic measurement of organ volume: Validation in the urinary bladder. J Ultrasound Med 1996; 15(9):627-32.
  8. The reliability of virtual organ computer-aided analysis (VOCAL) for the semiquantification of ovarian, endometrial and subendometrial perfusion. Ultrasound Obstet Gynecol 2003;22(6):633-39.
  9. The interobserver reliability of three-dimensional power Doppler data acquisition within the female pelvis. Ultrasound Obstet Gynecol 2004;23(5):501-08.
  10. Uterine anomalies. How common are they, and what is their distribution among subtypes? J Reprod Med 1998; 43(10):877-87.
  11. Prevalence and diagnosis of congenital uterine anomalies in women with reproductive failure: A critical appraisal. Hum Reprod Update 2008; Epub ahead of print.
  12. Mullerian duct anomalies: Imaging and clinical issues. Radiology 2004;233(1):19-34.
  13. Reproductive impact of congenital Müllerian anomalies. Hum Reprod 1997;12(10):2277-81.
  14. Diagnosis of Mullerian anomalies in adults: Evaluation of practice. Fertil Steril 2008;89(1):219-22.
  15. Three-dimensional ultrasound for the assessment of uterine anatomy and detection of congenital anomalies: A comparison with hysterosalpingography and two-dimensional sonography. Ultrasound Obstet Gynecol 1995;5(4):233-37.
  16. Congenital Mullerian anomalies: Diagnostic accuracy of three-dimensional ultrasound. Fertil Steril 1996;65(3):523-28.
  17. Detection of congenital mullerian duct anomalies using three-dimensional ultrasound. J Clin Ultrasound 1997;25(9):487-92.
  18. Magnetic resonance in the evaluation of Mullerian duct anomalies. Radiol Med (Torino) 1995;89(1-2):105-11.
  19. Reproductive outcomes in women with uterine anomalies. J Womens Health (Larchmt) 2004;13(1):33-39.
  20. Hysteroscopic metroplasty improves gestational outcome in women with recurrent spontaneous abortion. J Am Assoc Gynecol Laparosc 2004;11(2):240-44.
  21. Septate uterus: Reproductive outcome after hysteroscopic metroplasty. Clin Exp Obstet Gynecol 2006;33(2):110-12.
  22. Significance of endometrial polyps detected hysteroscopically in eumenorrheic infertile women. J Obstet Gynaecol Res 2004;30(2):84-89.
  23. Pregnancy rates after hysteroscopic polypectomy and myomectomy in infertile women. Obstet Gynecol 1999;94(2):168-71.
  24. Saline contrast sonohysterography as first-line investigation for women with uterine bleeding. Ultrasound Obstet Gynecol 1997;10(2):121-25.
  25. The value of transvaginal sonography with and without saline instillation in the diagnosis of uterine pathology in pre- and postmenopausal women with abnormal bleeding or suspect sonographic findings. Ultrasound Obstet Gynecol 1997;9(1):53-58.
  26. Prediction of implantation by the sonographic appearance of the endometrium during controlled ovarian stimulation for in vitro fertilization (IVF). J In Vitro Fert Embryo Transf 1990;7(3):146-52.
  27. Sonographic evaluation of the endometrium in in vitro fertilization IVF cycles. A way to predict pregnancy? Acta Obstet Gynecol Scand 1992;71(8):624-28.
  28. Assessment of endometrial receptivity for gestation in patients undergoing in vitro fertilization, using endometrial thickness and the endometrium-myometrium relative echogenicity coefficient. Ultrasound Obstet Gynecol 1999;14(3): 194-99.
  29. Endometrial and subendometrial perfusion are impaired in women with unexplained subfertility. Hum Reprod 2004;19(11):2605-14.
  30. Are endometrial parameters by three-dimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome? Fertil Steril 2008;89(1):111-17.
  31. Role of three-dimensional ultrasonographic measurement of endometrium volume as a predictor of pregnancy outcome in an IVF-ET program: A preliminary study. Fertil Steril 2000;74(4):797-801.
  32. Evaluation of endometrial receptivity during invitro fertilization using three-dimensional power Doppler ultrasound. Ultrasound Obstet Gynecol 2005;26(7):765-69.
  33. The role of endometrial and subendometrial vascularity measured by three-dimensional power Doppler ultrasound in the prediction of pregnancy during frozen-thawed embryo transfer cycles. Hum Reprod 2006; 21(6):1612-17.
  34. The role of endometrial and subendometrial blood flows measured by three-dimensional power Doppler ultrasound in the prediction of pregnancy during IVF treatment. Hum Reprod 2006;21(1):164-70.
  35. Three-dimensional endometrial volume calculation and pregnancy rate in an in-vitro fertilization programme. Hum Reprod 1999;14(5):1255-58.
  36. Endometrial volume as assessed by threedimensional ultrasound is a predictor of pregnancy outcome after in vitro fertilization and embryo transfer. Fertil Steril 2003;80(6):1515-17.
  37. Assessment of endometrial volume by three-dimensional ultrasound prior to embryo transfer: Clues to endometrial receptivity. Hum Reprod 1999;14(11):2851-54.
  38. Quantitative assessment of subendometrial blood flow by three-dimensional-ultrasound is an important predictive factor of implantation in an in-vitro fertilization programme. Hum Reprod 2000;15(1):89-94.
  39. Assessment of endometrial receptivity by transvaginal color Doppler and threedimensional power Doppler ultrasonography in patients undergoing in vitro fertilization procedures. J Ultrasound Med 2001;20(2):125-34.
  40. Detection of the subendometrial vascularization flow index by three-dimensional ultrasound may be useful for predicting the pregnancy rate for patients undergoing in vitro fertilizationembryo transfer. Fertil Steril 2003;79(3):507-11.
  41. Three-dimensional power Doppler ultrasound of the subendometrial blood flow under the administration of a contrast agent (Levovist). Arch Gynecol Obstet 2004;270(2):94-98.
  42. Age-specific FSH levels as a tool for appropriate patient counselling in assisted reproduction. Hum Reprod 2005;20(9):2448-52.
  43. Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in-vitro fertilization can predict poor response. Hum Reprod 1997;12(2):294-97.
  44. Ultrasonography as a tool for the prediction of outcome in IVF patients: A comparative meta-analysis of ovarian volume and antral follicle count. Fertil Steril 2007;87(4):764-75.
  45. Intraobserver and interobserver reproducibility of ovarian volume, antral follicle count, and vascularity indices obtained with transvaginal 3-dimensional ultrasonography, power Doppler angiography, and the virtual organ computer-aided analysis imaging program. J Ultrasound Med 2005;24(9):1279-87.
  46. Quantitative transvaginal two- and threedimensional sonography of the ovaries: Reproducibility of antral follicle counts. Ultrasound Obstet Gynecol 2002;20(3):270-75.
  47. Does 3D ultrasound offer any advantage in the pretreatment assessment of ovarian reserve and prediction of outcome after assisted reproduction treatment? Hum Reprod 2007;22(7):1932-41.
  48. Evaluation of the ovarian reserve in young low responders with normal basal levels of follicle-stimulating hormone using three-dimensional ultrasonography. Fertil Steril 1998;70(4):671-75.
  49. Ovarian stromal vascularity is not predictive of ovarian response and pregnancy. Reprod Biomed Online 2006;12(1):43-49.
  50. Predictors of IVF outcome by threedimensional ultrasound. Hum Reprod 2002;17(4):950-55.
  51. Three-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age. Fertil Steril 2003;79(1):190-97.
  52. Quantification of ovarian power Doppler signal with three-dimensional ultrasonography to predict response during in vitro fertilization. Obstet Gynecol 2003;102(4):816-22.
  53. The role of ovarian volume in an in vitro fertilization programme as assessed by 3D ultrasound. Arch Gynecol Obstet 2001;265(2):67-72.
  54. Quantification of ovarian stromal Doppler signals in poor responders undergoing in vitro fertilization with three-dimensional power Doppler ultrasonography. Am J Obstet Gynecol 2004; 190(2):338-44.
  55. Quantification of ovarian Doppler signal in hyperresponders during in vitro fertilization treatment using three-dimensional power Doppler ultrasonography. Ultrasound Med Biol 2003;29(7): 921-27.
  56. Ultrasound assessment of the polycystic ovary: International consensus definitions. Hum Reprod Update 2003;9(6):505-14.
  57. The role of three-dimensional ultrasonography in polycystic ovary syndrome. Hum Reprod 2006;21(9):2209-15.
  58. Diagnosis of polycystic ovaries by threedimensional transvaginal ultrasound. Fertil Steril 2006; 85(1):214-19.
  59. Ultrasound examination of polycystic ovaries: Is it worth counting the follicles? Hum Reprod 2003;18(3):598-603.
  60. Three-dimensional ultrasound features of the polycystic ovary and the effect of different phenotypic expressions on these parameters. Hum Reprod 2007;22(12):3116-23.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.